MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$867K
Free Cash flow
-$2,160K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from 2026 private place...
Accounts payable
Accrued liabilities
Others
Negative Cash Flow Breakdown
Other liabilities
Purchase of property and equipme...
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,420
676
-3,369
-4,892
Non-cash operating lease expense
2
9
11
158
Interest expense on finance leases
1
-
-
-
Depreciation and amortization
40
40
38
50
Stock-based compensation expense
19
42
376
36
Change in fair value of warrant liabilities
485
-3,110
1,595
4,309
Change in fair value of march 2025 convertible notes
-
-
0
-170
Loss upon issuance of march 2025 convertible notes carried at fair value
-
-
0
1,198
Loss on impairment and disposal of property and equipment
-1
-1
0
0
Financing expense for entering into 2025 lincoln park equity line of credit
-
-
412
-
Accounts receivable
61
217
-110
39
Prepaid expenses and other assets
-122
-120
429
-245
Inventories
-61
36
-24
9
Accounts payable
785
731
-574
68
Accrued liabilities
282
5
-670
138
Other liabilities
-1,327
1,380
495
-154
Net cash used in operating activities
-2,010
-359
-1,981
-212
Purchase of property and equipment
150
-
8
8
Purchase of intangible assets
-
-
0
385
Net cash used in investing activities
-150
-
-8
-393
Principal repayment of decd loan
59
59
59
58
Proceeds from issuance of common stock-Two Thousand Twenty Four At The Market Offering Agreement
-
-
0
3,484
Payment of stock issuance costs-Two Thousand Twenty Four At The Market Offering Agreement
-
-
0
147
Proceeds from issuance of common stock-Two Thousand Twenty Five Private Placement Offering
-
-
0
2,949
Payment of stock issuance costs-Two Thousand Twenty Five Private Placement Offering
-
-
6
134
Proceeds from issuance of common stock from exercise of warrants
-
-
0
112
Proceeds from 2026 private placement offering
1,410
-
-
-
Proceeds from march 2025 convertible notes
-
-
0
0
Payment of issuance costs-Two Thousand Twenty Six Private Placement Offering
58
-
-
-
Proceeds from issuance of common stock-Equity Line Of Credit Agreement
-
-
25
-
Proceeds from 2025 equity purchase agreement
-
-18
-
0
Proceeds from issuance-Equity Purchase Agreement2025
7
-
-
-
Net cash provided by financing activities
1,293
-52
-65
2,869
Net decrease in cash and cash equivalents
-867
-411
-2,054
2,264
Cash and cash equivalents, beginning of period
1,344
1,755
3,809
1,769
Cash and cash equivalents, end of period
477
1,344
1,755
3,809
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from 2026
private placement...
$1,410K
Net cash provided by
financing activities
$1,293K
(-71.96%↓ Y/Y)
Canceled cashflow
$117K
Net decrease in cash
and cash...
-$867K
(-287.05%↓ Y/Y)
Canceled cashflow
$1,293K
Accounts payable
$785K
(282.56%↑ Y/Y)
Change in fair value of
warrant liabilities
$485K
(263.30%↑ Y/Y)
Accrued liabilities
$282K
(145.78%↑ Y/Y)
Prepaid expenses and
other assets
-$122K
(71.36%↑ Y/Y)
Inventories
-$61K
(-15.09%↓ Y/Y)
Depreciation and
amortization
$40K
(66.67%↑ Y/Y)
Stock-based compensation
expense
$19K
(-84.03%↓ Y/Y)
Non-cash operating lease
expense
$2K
Loss on impairment
and disposal of...
-$1K
(0.00%↑ Y/Y)
Interest expense on
finance leases
$1K
Principal repayment of
decd loan
$59K
(-49.14%↓ Y/Y)
Payment of issuance
costs-Two Thousand Twenty...
$58K
Net cash used in
operating activities
-$2,010K
(58.44%↑ Y/Y)
Canceled cashflow
$1,798K
Net cash used in
investing activities
-$150K
Net loss
-$2,420K
(46.45%↑ Y/Y)
Other liabilities
-$1,327K
(-189.11%↓ Y/Y)
Accounts receivable
$61K
(-78.82%↓ Y/Y)
Purchase of property and
equipment
$150K
Buy us a coffee
Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. (AWHL)